US Stock MarketDetailed Quotes

CATX Perspective Therapeutics

Watchlist
  • 2.560
  • +0.090+3.64%
Close May 2 16:00 ET
  • 2.560
  • 0.0000.00%
Post 20:01 ET
189.57MMarket Cap-2.08P/E (TTM)

Perspective Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
63.15%66.8M
78.62%20.9M
91.12%18.63M
46.23%14.26M
33.54%13.01M
386.93%40.94M
285.82%11.7M
246.11%9.75M
9.75M
9.74M
Selling and administrative expenses
26.34%26.61M
66.92%8.25M
55.90%6.98M
10.57%5.51M
-11.78%5.88M
196.38%21.06M
120.93%4.94M
97.27%4.47M
--4.99M
--6.66M
-General and administrative expense
26.34%26.61M
66.92%8.25M
55.90%6.98M
10.57%5.51M
-11.78%5.88M
280.22%21.06M
203.25%4.94M
182.99%4.47M
--4.99M
--6.66M
Research and development costs
95.38%41.64M
81.96%12.88M
116.64%12.03M
72.72%9.28M
125.20%7.45M
1,538.05%21.31M
789.45%7.08M
911.29%5.55M
--5.37M
--3.31M
Other operating expenses
-1.39%-1.45M
27.33%-234K
-33.70%-369K
12.77%-526K
-39.48%-325K
---1.43M
---322K
---276K
---603K
---233K
Operating profit
-63.15%-66.8M
-78.62%-20.9M
-91.12%-18.63M
-46.23%-14.26M
-33.54%-13.01M
-439.34%-40.94M
-455.46%-11.7M
-608.58%-9.75M
-9.75M
-9.74M
Net non-operating interest income expense
1,128.52%10.47M
7,057.89%2.72M
1,748.42%3.51M
1,039.18%3.05M
232.02%1.18M
51.87%852K
35.71%38K
555.17%190K
268K
356K
Non-operating interest income
1,025.80%10.52M
4,169.35%2.65M
1,655.39%3.58M
946.26%3.08M
223.80%1.21M
66.49%934K
121.43%62K
603.45%204K
--294K
--374K
Non-operating interest expense
-41.46%48K
-404.17%-73K
392.86%69K
-11.54%23K
61.11%29K
--82K
--24K
--14K
--26K
--18K
Other net income (expense)
-141,647.06%-24.1M
-141,811.76%-24.09M
-4K
90.91%-2K
94.43%-17K
17K
-12K
-22K
Earnings from equity interest
52.94%-8K
60.00%-2K
--0
---4K
---2K
---17K
---5K
---12K
--0
--0
Special income (charges)
---24.09M
-109,595.45%-24.09M
--0
--0
--0
--0
--22K
--0
--0
---22K
-Less:Impairment of capital assets
--24.06M
----
----
----
----
--0
----
----
----
----
-Gain on sale of property,plant,equipment
---27K
-222.73%-27K
--0
--0
--0
--0
--22K
--0
--0
---22K
Income before tax
-100.54%-80.43M
-263.02%-42.27M
-57.98%-15.12M
-18.22%-11.21M
-25.73%-11.83M
-446.78%-40.11M
-460.30%-11.64M
-610.62%-9.57M
-9.49M
-9.41M
Income tax
20.90%-2.1M
-126.72%-2.1M
0
0
0
-2.65M
7.85M
0
0
-10.5M
Net income
-70.46%-79.28M
-62.79%-40.17M
-46.02%-15.12M
-5.38%-11.7M
-3,211.05%-12.28M
-534.06%-46.51M
-1,087.44%-24.68M
-668.82%-10.36M
-11.11M
-371K
Net income continuous Operations
-109.13%-78.33M
-106.08%-40.17M
-57.98%-15.12M
-18.22%-11.21M
-1,179.91%-11.83M
-410.63%-37.46M
-838.02%-19.49M
-610.62%-9.57M
---9.49M
--1.1M
Net income discontinuous operations
89.52%-949K
98.86%-59K
--0
73.52%-429K
68.55%-461K
---9.05M
---5.18M
---784K
---1.62M
---1.47M
Net income extraordinary
----
----
--0
---61K
--2K
----
----
--0
--0
--0
Minority interest income
Net income attributable to the parent company
-70.46%-79.28M
-62.79%-40.17M
-46.02%-15.12M
-5.38%-11.7M
-3,211.05%-12.28M
-534.06%-46.51M
-1,087.44%-24.68M
-668.82%-10.36M
-11.11M
-371K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-70.46%-79.28M
-62.79%-40.17M
-46.02%-15.12M
-5.38%-11.7M
-3,211.05%-12.28M
-534.06%-46.51M
-1,087.44%-24.68M
-668.82%-10.36M
-11.11M
-371K
Basic earnings per share
29.31%-1.23
30.33%-0.61
94.32%-0.21
55.00%-0.18
-0.2
-248.00%-1.74
-775.59%-0.8756
-3,600.00%-3.7
-0.4
0
Diluted earnings per share
29.31%-1.23
30.33%-0.61
94.32%-0.21
55.00%-0.18
-0.2
-248.00%-1.74
-775.59%-0.8756
-3,600.00%-3.7
-0.4
0
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 63.15%66.8M78.62%20.9M91.12%18.63M46.23%14.26M33.54%13.01M386.93%40.94M285.82%11.7M246.11%9.75M9.75M9.74M
Selling and administrative expenses 26.34%26.61M66.92%8.25M55.90%6.98M10.57%5.51M-11.78%5.88M196.38%21.06M120.93%4.94M97.27%4.47M--4.99M--6.66M
-General and administrative expense 26.34%26.61M66.92%8.25M55.90%6.98M10.57%5.51M-11.78%5.88M280.22%21.06M203.25%4.94M182.99%4.47M--4.99M--6.66M
Research and development costs 95.38%41.64M81.96%12.88M116.64%12.03M72.72%9.28M125.20%7.45M1,538.05%21.31M789.45%7.08M911.29%5.55M--5.37M--3.31M
Other operating expenses -1.39%-1.45M27.33%-234K-33.70%-369K12.77%-526K-39.48%-325K---1.43M---322K---276K---603K---233K
Operating profit -63.15%-66.8M-78.62%-20.9M-91.12%-18.63M-46.23%-14.26M-33.54%-13.01M-439.34%-40.94M-455.46%-11.7M-608.58%-9.75M-9.75M-9.74M
Net non-operating interest income expense 1,128.52%10.47M7,057.89%2.72M1,748.42%3.51M1,039.18%3.05M232.02%1.18M51.87%852K35.71%38K555.17%190K268K356K
Non-operating interest income 1,025.80%10.52M4,169.35%2.65M1,655.39%3.58M946.26%3.08M223.80%1.21M66.49%934K121.43%62K603.45%204K--294K--374K
Non-operating interest expense -41.46%48K-404.17%-73K392.86%69K-11.54%23K61.11%29K--82K--24K--14K--26K--18K
Other net income (expense) -141,647.06%-24.1M-141,811.76%-24.09M-4K90.91%-2K94.43%-17K17K-12K-22K
Earnings from equity interest 52.94%-8K60.00%-2K--0---4K---2K---17K---5K---12K--0--0
Special income (charges) ---24.09M-109,595.45%-24.09M--0--0--0--0--22K--0--0---22K
-Less:Impairment of capital assets --24.06M------------------0----------------
-Gain on sale of property,plant,equipment ---27K-222.73%-27K--0--0--0--0--22K--0--0---22K
Income before tax -100.54%-80.43M-263.02%-42.27M-57.98%-15.12M-18.22%-11.21M-25.73%-11.83M-446.78%-40.11M-460.30%-11.64M-610.62%-9.57M-9.49M-9.41M
Income tax 20.90%-2.1M-126.72%-2.1M000-2.65M7.85M00-10.5M
Net income -70.46%-79.28M-62.79%-40.17M-46.02%-15.12M-5.38%-11.7M-3,211.05%-12.28M-534.06%-46.51M-1,087.44%-24.68M-668.82%-10.36M-11.11M-371K
Net income continuous Operations -109.13%-78.33M-106.08%-40.17M-57.98%-15.12M-18.22%-11.21M-1,179.91%-11.83M-410.63%-37.46M-838.02%-19.49M-610.62%-9.57M---9.49M--1.1M
Net income discontinuous operations 89.52%-949K98.86%-59K--073.52%-429K68.55%-461K---9.05M---5.18M---784K---1.62M---1.47M
Net income extraordinary ----------0---61K--2K----------0--0--0
Minority interest income
Net income attributable to the parent company -70.46%-79.28M-62.79%-40.17M-46.02%-15.12M-5.38%-11.7M-3,211.05%-12.28M-534.06%-46.51M-1,087.44%-24.68M-668.82%-10.36M-11.11M-371K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -70.46%-79.28M-62.79%-40.17M-46.02%-15.12M-5.38%-11.7M-3,211.05%-12.28M-534.06%-46.51M-1,087.44%-24.68M-668.82%-10.36M-11.11M-371K
Basic earnings per share 29.31%-1.2330.33%-0.6194.32%-0.2155.00%-0.18-0.2-248.00%-1.74-775.59%-0.8756-3,600.00%-3.7-0.40
Diluted earnings per share 29.31%-1.2330.33%-0.6194.32%-0.2155.00%-0.18-0.2-248.00%-1.74-775.59%-0.8756-3,600.00%-3.7-0.40
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More